As per MRFR analysis, the GCC IVD Contract Manufacturing Market Size was estimated at 159.53 (USD Million) in 2023.The GCC IVD Contract Manufacturing Market is expected to grow from 166.95(USD Million) in 2024 to 431.2 (USD Million) by 2035. The GCC IVD Contract Manufacturing Market CAGR (growth rate) is expected to be around 9.009% during the forecast period (2025 - 2035).
Key GCC IVD Contract Manufacturing Market Trends Highlighted
The market for GCC IVD contract manufacturing is expanding significantly due to the region's growing healthcare infrastructure and the rise in demand for diagnostic testing. One of the main factors driving the market is the GCC governments' growing investments in healthcare, especially in nations like Saudi Arabia and the United Arab Emirates, as part of their Vision 2030 programs.
Enhancing local manufacturing skills through public-private partnerships is the main goal of these initiatives, which is essential for IVD development. increasingly advanced diagnostics are also required because chronic diseases are becoming increasingly common in the area.
There are chances for both domestic and foreign companies to work together, offering cutting-edge manufacturing solutions while abiding by the regulations established by the Gulf Cooperation Council. Additionally, by encouraging localised production, businesses can set up shop in the GCC, lowering their reliance on imports and guaranteeing faster access to the market.
Current patterns show an increasing interest in cutting-edge technologies that are changing the diagnostics landscape in the area, like personalised medicine and point-of-care testing. Additionally, the COVID-19 pandemic has increased stakeholder awareness of the value of local manufacturing capabilities and hastened the need for rapid testing solutions.
The GCC IVD contract manufacturing market is being further shaped by increased government support in the form of incentives and policies meant to promote biomedical R&D. All things considered, rising investments, the need for regional solutions, and technology developments are important factors that will continue to shape the GCC market environment.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
GCC IVD Contract Manufacturing Market Drivers
Increasing Demand for Diagnostic Tests
The GCC IVD Contract Manufacturing Market is witnessing a surge in demand for diagnostic tests, driven by an increasing prevalence of chronic diseases and the necessity for timely disease detection.
For instance, the World Health Organization has reported a rise in lifestyle-related diseases in Gulf Cooperation Council countries, with diabetes prevalence in the United Arab Emirates estimated at 19.3% as of recent years. This escalating healthcare challenge compels governments and healthcare providers to invest in advanced diagnostic tools.
Major organizations such as Siemens Healthineers and Roche Diagnostics are responding to this critical need by expanding their operations in GCC countries, thereby enhancing local manufacturing capabilities and meeting demand efficiently.
The improved access to locally manufactured IVD products aligns with government efforts in the GCC region to strengthen healthcare infrastructure, thus driving growth in the contract manufacturing segment.
Government Initiatives to Improve Healthcare
Governments across the GCC region are actively pushing for enhanced healthcare frameworks by implementing various initiatives aimed at improving healthcare outcomes. The Saudi Vision 2030, for instance, highlights the focus on advanced medical technologies and enhancing diagnostic capabilities as core components of the healthcare strategy.
Such national policies encourage investments in the Gulf Cooperation Council IVD Contract Manufacturing Market. As a byproduct, improvements in local manufacturing facilities directly correlate with the increase in production of innovative IVD products.
The comprehensive approach towards healthcare denotes a growing commitment to facilitating better health outcomes, which consequently stimulates the demand for contract manufacturing services in IVD.
Technological Advancements in IVD Products
Technological advancements in In Vitro Diagnostics (IVD) are significantly propelling the growth of the GCC IVD Contract Manufacturing Market. Innovations such as point-of-care testing, the integration of artificial intelligence in diagnostics, and next-generation sequencing are revolutionizing the field.
According to recent data from the Gulf Health Council, it is projected that the adoption of such technologies can lead to a 30% reduction in diagnostic errors, thereby enhancing patient care.
Prominent manufacturers, including Abbott Laboratories and Genomind, are investing in developing cutting-edge diagnostic technologies within the GCC. Their efforts not only improve the quality of diagnostic tests but also create opportunities for local contract manufacturers, thus driving market growth.
GCC IVD Contract Manufacturing Market Segment Insights
IVD Contract Manufacturing Market Product Type Insights
The GCC IVD Contract Manufacturing Market reflects a dynamic landscape shaped predominantly by a diverse array of product types, each contributing uniquely to the overall market performance and tailored to meet the rising demand for diagnostic solutions in the region.
Reagents play a fundamental role, serving as essential components in various diagnostic procedures, thereby ensuring accuracy and efficiency in patient testing processes. The market showcases a significant inclination towards Diagnostic Devices, driven by advancements in technology and an increasing focus on early and precise disease detection.
The incorporation of innovative technologies in devices not only enhances user experience but also raises the bar for effectiveness in diagnostics. Assay Kits are another crucial element within this market space, facilitating streamlined testing processes and ensuring a high degree of reliability in results.
Their versatility allows for a wide range of applications, catering to various therapeutic areas and driving their demand further. Moreover, Consumables constitute a critical segment as they encompass a wide variety of necessary materials used across various diagnostic applications, highlighting their significance in maintaining workflow efficiency and supporting seamless laboratory operations.
In the rapidly evolving healthcare sector, growth drivers such as increased healthcare expenditure, rising prevalence of chronic diseases, and an upsurge in the aging population contribute to the market's expansion across the GCC.
The region's commitment to healthcare excellence and the emphasis on local manufacturing capabilities further bolster the GCC IVD Contract Manufacturing Market, echoing the strategic importance of enhancing regional supply chains.
However, the market does face challenges, including stringent regulatory frameworks and the need for continuous innovation to keep pace with technological advancements.
Overall, the product type segmentation showcases a balanced interplay among various components that are essential in reinforcing the GCC’s position in the global IVD landscape while reflecting its unique market trends, growth patterns, and opportunities for advancement.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
IVD Contract Manufacturing Market Technology Insights
The Technology segment within the GCC IVD Contract Manufacturing Market showcases a dynamic landscape, characterized by various essential areas such as Molecular Diagnostics, Immunoassays, Clinical Chemistry, and Microbiology. Each of these areas plays a pivotal role in the advancements of diagnostic processes in the region.
Molecular Diagnostics has emerged as a key player, driven by increasing demands for accurate and rapid testing, especially in infectious diseases and genetic disorders. Immunoassays are crucial for their versatility in detecting biomarkers, offering significant applications in clinical settings, including disease diagnosis and monitoring treatment responses.
Clinical Chemistry remains significant due to its extensive use in routine laboratory tests, catering to a wide array of health concerns across the GCC. Meanwhile, Microbiology is vital for understanding pathogens and ensuring public health safety, an area of growing importance as the region addresses emerging health challenges.
Together, these areas within the Technology segment not only drive innovation but also enhance the overall efficiency and effectiveness of the IVD landscape in the GCC, reflecting the region's commitment to advancing healthcare solutions and addressing its unique health challenges.
IVD Contract Manufacturing Market End-user Insights
The End-user segment within the GCC IVD Contract Manufacturing Market plays a vital role in the overall landscape of the industry, catering to diverse needs across multiple sectors. Hospitals are crucial in this segment as they are primary locations for diagnostics and patient care, driving demand for innovative in vitro diagnostic (IVD) products.
Diagnostic Laboratories support the need for specialized testing, ensuring accuracy and efficiency in patient diagnostics, which is pivotal for timely treatments. Research Institutions contribute significantly to the advancement of medical knowledge, often focusing on biomedical research and technology innovation, making them essential for the development of new diagnostic tools.
The Home Care sector represents a growing trend towards personalized healthcare, allowing patients to monitor their health conditions conveniently, which is particularly important in light of the increasing focus on patient-centric care models in the GCC region.
This diversified End-user distribution enhances the robustness of the GCC IVD Contract Manufacturing Market, ensuring that it aligns with both current healthcare demands and future innovations.
The market continues to evolve with trends such as digital health integration, increased regulatory emphasis on quality standards, and a shift towards personalized medicine, presenting opportunities for stakeholders and driving market growth as it adapts to the unique healthcare needs in the GCC.
IVD Contract Manufacturing Market Service Type Insights
The GCC IVD Contract Manufacturing Market is experiencing a pivotal growth trajectory, primarily driven by the Service Type segment, which includes Manufacturing Services, Research and Development Services, and Packaging Services.
Manufacturing Services play a crucial role in supplying high-quality diagnostics products that meet stringent regulatory requirements, thereby ensuring safety and efficacy in the region. Research and Development Services are significant as they foster innovation and adaptation of new technologies in the diagnostic sector, addressing the unique healthcare needs within the GCC states.
Packaging Services are equally important, providing tailored solutions that enhance product protection and compliance, reflecting the cultural and legal aspects of the region.
The segmentation of the market allows for targeted strategies as various stakeholders seek specialized services that align with local regulations and market demands in countries like Saudi Arabia and the UAE, known for their growing investments in the healthcare infrastructure.
Overall, the Service Type segment embodies the complexities and opportunities of the GCC IVD Contract Manufacturing Market, underlining the importance of adaptability and expertise in meeting the growing healthcare needs across the region.
GCC IVD Contract Manufacturing Market Key Players and Competitive Insights
The competitive insights of the GCC IVD Contract Manufacturing Market highlight a dynamic landscape characterized by rapidly evolving technologies, stringent regulatory frameworks, and an increasing demand for innovative diagnostic solutions.
The market is witnessing a surge in collaboration between contract manufacturers and in vitro diagnostic (IVD) developers to enhance product offerings and meet the growing healthcare needs within the region. Factors such as the rising prevalence of chronic diseases, an increasing geriatric population, and growing awareness of early disease detection are driving the demand for high-quality IVD products.
As a result, companies operating in this market are focusing on strategic partnerships, investments in advanced manufacturing technologies, and expanding their production capacities to maintain a competitive edge in the GCC.
Abbott Laboratories enjoys a robust presence in the GCC IVD Contract Manufacturing Market due to its commitment to innovation and quality. The company leverages its extensive expertise in diagnostics to deliver a diverse portfolio of IVD products that cater to various medical needs.
Its strengths lie in its strong research and development capabilities, allowing Abbott Laboratories to continuously introduce advanced diagnostics solutions tailored to the regional market. With a well-established distribution network and a reputation for reliability, Abbott Laboratories has successfully positioned itself as a trusted partner for healthcare providers in the GCC.
The company's proactive approach to compliance with local regulations and its focus on customer satisfaction further enhance its competitive stance in the region.
Thermo Fisher Scientific holds a prominent position in the GCC IVD Contract Manufacturing Market, driven by its expansive range of key products and services that address the unique demands of this sector. With a focus on cutting-edge technologies, Thermo Fisher Scientific provides innovative diagnostics solutions, including assay development and system integration services.
The company’s strengths are amplified through strategic mergers and acquisitions, enabling Thermo Fisher Scientific to broaden its capabilities and enhance its product offerings tailored for the GCC region. Its commitment to quality and continuous improvement resonates well with local healthcare providers seeking reliable and innovative IVD solutions.
Thermo Fisher Scientific’s established market presence is supported by its ability to engage in collaboration with local stakeholders, ensuring that it remains at the forefront of the GCC IVD manufacturing landscape while contributing to improved healthcare outcomes in the region.
Key Companies in the GCC IVD Contract Manufacturing Market Include:
GCC IVD Contract Manufacturing Market Developments
Recent developments in the GCC In Vitro Diagnostics (IVD) Contract Manufacturing Market have been significant, reflecting an increasing demand for advanced healthcare solutions in the region. Companies such as Abbott Laboratories and Thermo Fisher Scientific are expanding their manufacturing capabilities to meet the growing healthcare needs spurred by the COVID-19 pandemic and other health challenges.
Celerion and Siemens Healthineers have also made strides in enhancing their R&D facilities within the GCC to boost local production of diagnostic products. Notably, in October 2023, BD announced the launch of new diagnostic assays, enhancing its product portfolio in the GCC.
Additionally, the trend of mergers and acquisitions continues, with Roche Diagnostics acquiring a local biotech firm aimed at bolstering their diagnostic capabilities. Moreover, market valuations for firms such as PerkinElmer and Mylab Discovery Solutions are rising, driven by increased investment in healthcare infrastructure.
Over the past three years, major growth was observed when Hologic acquired a diagnostics company in December 2021, illustrating a robust trend toward consolidation in the IVD sector. These developments underscore a dynamic market responding effectively to regional health demands and technological advancements.
GCC IVD Contract Manufacturing Market Segmentation Insights
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 159.53(USD Million) |
| MARKET SIZE 2024 | 166.95(USD Million) |
| MARKET SIZE 2035 | 431.2(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.009% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Abbott Laboratories, Thermo Fisher Scientific, Celerion, Siemens Healthineers, PerkinElmer, Mylab Discovery Solutions, DiaSorin, F. HoffmannLa Roche, BD, BioRad Laboratories, Hologic, Ortho Clinical Diagnostics, Alere, Roche Diagnostics, Abcam |
| SEGMENTS COVERED | Product Type, Technology, End User, Service Type |
| KEY MARKET OPPORTUNITIES | Increased regional healthcare investments, Rising demand for customized diagnostics, Expansion of telehealth services, Growth in preventive healthcare measures, Partnerships with innovative startups |
| KEY MARKET DYNAMICS | Increasing demand for diagnostics, Technological advancements in IVD, Regulatory changes and compliance, Cost efficiency in manufacturing, Rising healthcare investments |
| COUNTRIES COVERED | GCC |
Frequently Asked Questions (FAQ) :
The projected market value of the GCC IVD Contract Manufacturing Market in 2024 is 166.95 million USD.
By 2035, the estimated market value of the GCC IVD Contract Manufacturing Market is expected to reach 431.2 million USD.
The expected CAGR for the GCC IVD Contract Manufacturing Market from 2025 to 2035 is 9.009%.
In 2035, the diagnostic devices segment is expected to have the highest market value at 130.0 million USD.
The reagents segment is projected to be valued at 105.0 million USD by 2035.
Major players in the GCC IVD Contract Manufacturing Market include Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, and Roche Diagnostics.
The anticipated market size for assay kits in 2024 is 38.0 million USD.
The expected market value for consumables in 2035 is estimated at 96.2 million USD.
Significant growth opportunities in the GCC IVD Contract Manufacturing sector arise from technological advancements and increasing demand for diagnostic solutions.
Current regional market dynamics, including healthcare investments and regulatory support, are positively impacting the growth of the GCC IVD Contract Manufacturing Market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
